EPO patient dispute: court battle ends at the start.
Gershon
D
D
D002617:Chemical Industry; D004921:Erythropoietin / Q000235:genetics; D005818:Genetic Engineering; D006801:Humans; D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011994:Recombinant Proteins; D014481:United States; D014486:United States Food and Drug Administration
D011994:Recombinant Proteins; D004921:Erythropoietin